306 related articles for article (PubMed ID: 16585133)
1. Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis.
Glossop JR; Dawes PT; Mattey DL
Rheumatology (Oxford); 2006 Oct; 45(10):1223-9. PubMed ID: 16585133
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
4. Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression.
Fabris M; Tolusso B; Di Poi E; Tomietto P; Sacco S; Gremese E; Ferraccioli G
J Rheumatol; 2005 Jun; 32(6):998-1005. PubMed ID: 15940758
[TBL] [Abstract][Full Text] [Related]
5. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis.
Mattey DL; Glossop JR; Nixon NB; Dawes PT
Arthritis Rheum; 2007 Dec; 56(12):3940-8. PubMed ID: 18050238
[TBL] [Abstract][Full Text] [Related]
8. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
Kawaguchi H; Ina Y; Ito S; Sato S; Sugiura Y; Tomita H; Ogisu N; Takada K; Yamamoto M; Morishita M; Yoshikawa K
Kekkaku; 1996 Mar; 71(3):259-65. PubMed ID: 8901228
[TBL] [Abstract][Full Text] [Related]
9. The role of soluble tumor necrosis factor receptor types I and II and tumor necrosis factor-alpha in malaria during pregnancy.
Davison BB; Kaack MB; Rogers LB; Rasmussen KK; Rasmussen TA; Henson EW; Henson MC; Parekh FK; Krogstad DJ
J Infect Dis; 2006 Jul; 194(1):123-32. PubMed ID: 16741891
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking and inflammatory indices in coronary artery disease.
Mizia-Stec K; Zahorska-Markiewicz B; Gasior Z
Int J Cardiol; 2004 Feb; 93(2-3):169-74. PubMed ID: 14975543
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis.
Kieszko R; Krawczyk P; Chocholska S; Bojarska-Junak A; Jankowska O; Król A; Roliński J; Milanowski J
Respir Med; 2007 Mar; 101(3):645-54. PubMed ID: 16889950
[TBL] [Abstract][Full Text] [Related]
14. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
15. Plasma TNF binding capacity in patients with juvenile idiopathic arthritis.
Bjørnhart B; Svenningsen P; Gudbrandsdottir S; Zak M; Nielsen S; Bendtzen K; Müller K
Int Immunopharmacol; 2005 Jan; 5(1):73-7. PubMed ID: 15589462
[TBL] [Abstract][Full Text] [Related]
16. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.
Vey E; Burger D; Dayer JM
Eur J Immunol; 1996 Oct; 26(10):2404-9. PubMed ID: 8898953
[TBL] [Abstract][Full Text] [Related]
17. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
Valle Y; Ledezma-Lozano IY; Torres-Carrillo N; Padilla-Gutiérrez JR; Navarro-Hernández RE; Vázquez-Del Mercado M; Palafox-Sánchez CA; Armendáriz-Borunda J; Muñoz-Valle JF
Scand J Rheumatol; 2009; 38(5):332-5. PubMed ID: 19579138
[TBL] [Abstract][Full Text] [Related]
18. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
[TBL] [Abstract][Full Text] [Related]
19. IL-12, IL-6 and IFN-gamma production by lymphocytes of pregnant women with rheumatoid arthritis remission during pregnancy.
Tchórzewski H; Krasomski G; Biesiada L; Głowacka E; Banasik M; Lewkowicz P
Mediators Inflamm; 2000; 9(6):289-93. PubMed ID: 11213913
[TBL] [Abstract][Full Text] [Related]
20. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
